Skip to main content
. 2022 Dec 16;101(50):e31440. doi: 10.1097/MD.0000000000031440

Table 2.

Clinical outcomes of endoscopic mucosal resection in the 2 randomized groups (PP analysis).

Antibiotic group Control group P value
Adverse events
 Fever 2 (1.7%) 3 (2.4%) 1
 Abdominal pain 12 (10.0%) 10 (7.9%) .571
 Bleeding* 10 (8.3%) 11 (8.7%) .911
White blood cell count
 Before surgery 6.01 ± 1.62 6.02 ± 1.77 .975
 1 d after surgery 6.18 ± 1.39 6.38 ± 1.41 .266
 3 d after surgery 5.77 ± 1.67 6.06 ± 1.99 .212
Erythrocyte sedimentation rate
 Before surgery 12.08 ± 7.01 12.89 ± 6.68 .317
 1 d after surgery 11.48 ± 10.18 11.10 ± 8.18 .741
 3 d after surgery 10.06 ± 8.15 10.92 ± 8.46 .417
C-reactive protein
 Before surgery 0.36 (0.36–0.36) 0.36 (0.36–0.36) .372
 1 d after surgery 0.36 (0.36–0.36) 0.36 (0.36–0.36) .732
 3 d after surgery 0.36 (0.36–0.36) 0.36 (0.36–0.36) .357
Procalcitonin
 Before surgery 0.025 (0.025–0.025) 0.025 (0.025–0.025) 1.000
 1 d after surgery 0.025 (0.025–0.100) 0.025 (0.025–0.100) .469
 3 d after surgery 0.025 (0.025–0.025) 0.025 (0.025–0.025) .324
*

Delayed bleeding was defined as bleeding symptoms or hemoglobin loss (≥ 2 g/dL) within 30 days after endoscopic mucosal resection, PP = per-protocol.